CRISPR Therapeutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2024 | 7.93 M | $372.40 M | 0.78% | 9.30% |
| ARK INVESTMENT MANAGEMENT LLC | 10/31/2024 | 7.50 M | $352.29 M | -3.60% | 8.80% |
| STATE STREET CORP | 11/14/2024 | 2.99 M | $140.61 M | 25.04% | 3.51% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 11/05/2024 | 2.97 M | $139.44 M | -5.82% | 3.48% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/07/2024 | 2.97 M | $139.37 M | -5.85% | 3.48% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.80 M | $131.32 M | 100.00% | 3.28% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 2.74 M | $128.61 M | 0.25% | 3.21% |
| FMR LLC | 11/13/2024 | 2.38 M | $111.63 M | 0.98% | 2.79% |
| VANGUARD GROUP INC | 11/13/2024 | 1.73 M | $81.06 M | -1.32% | 2.02% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 1.59 M | $74.60 M | 0.00% | 1.86% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 1.39 M | $65.27 M | 0.00% | 1.63% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1.08 M | $50.82 M | 14.89% | 1.27% |
| SR ONE CAPITAL MANAGEMENT, LP | 11/13/2024 | 1.05 M | $49.28 M | 0.00% | 1.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.01 M | $47.38 M | 3.62% | 1.18% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 945,267 | $44.41 M | -6.06% | 1.11% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 843,075 | $39.61 M | 743.08% | 0.99% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 824,606 | $38.74 M | -13.21% | 0.97% |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 11/08/2024 | 783,898 | $36.83 M | 14.32% | 0.92% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 724,241 | $34.02 M | 0.92% | 0.85% |
| CITADEL ADVISORS LLC | 11/14/2024 | 695,400 | $32.67 M | -2.17% | 0.82% |
| UBS GROUP AG | 11/14/2024 | 673,588 | $31.65 M | 58.78% | 0.79% |
| MORGAN STANLEY | 11/14/2024 | 632,003 | $29.69 M | 5.74% | 0.74% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 623,650 | $29.30 M | 587.87% | 0.73% |
| BELLEVUE GROUP AG | 11/14/2024 | 610,000 | $28.66 M | -1.24% | 0.72% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 604,700 | $28.41 M | 25.87% | 0.71% |
| CITADEL ADVISORS LLC | 11/14/2024 | 518,547 | $24.36 M | 263.73% | 0.61% |
| VERSANT VENTURE MANAGEMENT, LLC | 11/08/2024 | 498,558 | $23.42 M | 0.00% | 0.58% |
| BAILLIE GIFFORD & CO | 11/05/2024 | 364,768 | $17.14 M | -10.03% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 358,903 | $16.86 M | 37.61% | 0.42% |
| JPMORGAN CHASE & CO | 12/26/2024 | 354,242 | $16.64 M | 7.65% | 0.42% |
| CAPITAL ADVISORS INC/OK | 10/28/2024 | 300,589 | $14.12 M | 8.12% | 0.35% |
| CITADEL ADVISORS LLC | 11/14/2024 | 280,000 | $13.15 M | -24.53% | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 266,500 | $12.52 M | -15.80% | 0.31% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 263,400 | $12.37 M | -25.17% | 0.31% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 250,290 | $11.84 M | 31.45% | 0.29% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 248,979 | $11.70 M | -7.38% | 0.29% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 214,094 | $10.06 M | 17.27% | 0.25% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 209,840 | $9.86 M | -20.92% | 0.25% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 203,029 | $9.54 M | -10.80% | 0.24% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 200,000 | $9.40 M | 0.83% | 0.23% |
| EAGLE HEALTH INVESTMENTS LP | 11/12/2024 | 197,000 | $9.26 M | 0.00% | 0.23% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 186,761 | $8.77 M | 14.66% | 0.22% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 179,053 | $8.41 M | 949.61% | 0.21% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 11/14/2024 | 174,097 | $8.18 M | -11.90% | 0.20% |
| JANE STREET GROUP, LLC | 11/15/2024 | 171,430 | $8.05 M | -51.01% | 0.20% |
| CAPITAL INTERNATIONAL SARL | 11/13/2024 | 170,523 | $8.01 M | 14.14% | 0.20% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 166,263 | $7.81 M | 100.00% | 0.20% |
| SPEAR HOLDINGS RSC LTD | 10/17/2024 | 165,000 | $7.75 M | 0.00% | 0.19% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 159,644 | $7.55 M | 0.00% | 0.19% |
| SWISS NATIONAL BANK | 11/07/2024 | 157,600 | $7.40 M | -0.69% | 0.18% |
CRISPR Therapeutics AGinstitutional Ownership - FAQ's
During the previous two years, 557 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC: 0
Ridgewood Investments LLC: 0
Rise Advisors, LLC: 0
Miracle Mile Advisors, LLC: 0
Harbour Capital Advisors, LLC: 0
Capital International Investors: 7.93 M
69.75% of CRISPR Therapeutics AG stock is owned by institutional investors.
Institutional investors have bought a total of 64.39 M shares in the last 24 months. This purchase volume represents approximately $2.47 B in transactions.